Inspire Medical Systems, Inc. (INSP)

Market Cap	2.28B
Revenue (ttm)	861.31M
Net Income (ttm)	53.12M
Shares Out	29.57M
EPS (ttm)	1.74
PE Ratio	44.22
Forward PE	73.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,061,604
Open	79.75
Previous Close	78.45
Day's Range	76.38 - 79.92
52-Week Range	73.92 - 225.00
Beta	1.22
Analysts	Buy
Price Target	174.77 (+126.83%)
Earnings Date	Aug 4, 2025

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The comp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,246
• Stock Exchange: NYSE
• Ticker Symbol: INSP
• Website: https://www.inspiresleep.com

Analyst Summary

According to 14 analysts, the average rating for INSP stock is "Buy." The 12-month stock price target is $174.77, which is an increase of 126.83% from the latest price.

Price Target

$174.77

(126.83% upside)

Analyst Consensus: Buy